HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

M Ogawa Selected Research

Enzymes

11/2005New criteria for immunofluorescence assay for Q fever diagnosis in Japan.
7/2001O-helix mutant T664P of Thermus aquaticus DNA polymerase I: altered catalytic properties for incorporation of incorrect nucleotides but not correct nucleotides.
9/2000A potentially novel peptidase, resembling but distinct from neutrophil elastase, produced by carcinoma cells.
7/2000Expression levels of thymidine phosphorylase and dihydropyrimidine dehydrogenase in various human tumor tissues.
5/2000Medroxyprogesterone acetate inhibits human pancreatic carcinoma cell growth by inducing apoptosis in association with Bcl-2 phosphorylation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


M Ogawa Research Topics

Disease

32Neoplasms (Cancer)
03/2005 - 01/2000
9Pancreatic Neoplasms (Pancreatic Cancer)
12/2005 - 05/2000
9Carcinogenesis
11/2001 - 01/2000
8Stomach Neoplasms (Stomach Cancer)
06/2015 - 07/2000
8Carcinoma (Carcinomatosis)
01/2003 - 01/2000
7Hepatocellular Carcinoma (Hepatoma)
03/2003 - 05/2000
7Myocardial Infarction
09/2002 - 01/2000
6Infections
06/2013 - 03/2000
6Neoplasm Metastasis (Metastasis)
06/2003 - 11/2000
6Colorectal Neoplasms (Colorectal Cancer)
03/2003 - 01/2000
5Inflammation (Inflammations)
09/2018 - 01/2000
5Breast Neoplasms (Breast Cancer)
07/2015 - 01/2000
5Colonic Neoplasms (Colon Cancer)
11/2001 - 07/2000
4Lymphoma (Lymphomas)
01/2021 - 10/2001
4Pathologic Constriction (Stenosis)
10/2015 - 02/2000
4Pancreatitis
11/2001 - 08/2000
4Reperfusion Injury
12/2000 - 01/2000
3Parkinson Disease (Parkinson's Disease)
01/2020 - 01/2000
3Body Weight (Weight, Body)
06/2016 - 03/2001
3Neurologic Manifestations (Neurological Manifestations)
11/2015 - 06/2000
3Hemorrhage
03/2007 - 08/2000
3Alopecia (Baldness)
11/2006 - 05/2001
3Wounds and Injuries (Trauma)
02/2005 - 10/2000
3Fibrosis (Cirrhosis)
01/2005 - 07/2000
3Leukopenia
11/2001 - 02/2001
3Adenoma (Adenomas)
06/2001 - 01/2000
3Ischemia
12/2000 - 01/2000
2Disease Progression
09/2021 - 08/2017
2Lymphatic Metastasis
10/2015 - 10/2001
2Choriocarcinoma
07/2015 - 01/2012
2Abdominal Aortic Aneurysm
08/2012 - 04/2011
2Anemia
07/2010 - 02/2001
2Ulcer
07/2009 - 01/2003
2Hematoma
03/2007 - 07/2000
2Ascites
01/2003 - 05/2000
2Liver Failure
01/2003 - 10/2001
2Abscess
01/2003 - 03/2000
2Hyperplasia
07/2002 - 02/2000
2Citrullinemia
12/2001 - 01/2001
2Neutropenia
11/2001 - 10/2001
2Muscular Dystrophies (Muscular Dystrophy)
10/2001 - 08/2001
2Neoplasm Micrometastasis
09/2001 - 02/2001
2Esophageal Neoplasms (Esophageal Cancer)
07/2001 - 03/2001

Drug/Important Bio-Agent (IBA)

15CytokinesIBA
09/2018 - 01/2000
14Proteins (Proteins, Gene)FDA Link
09/2021 - 01/2000
6Messenger RNA (mRNA)IBA
01/2012 - 05/2000
6Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
03/2001 - 01/2000
5EnzymesIBA
11/2005 - 05/2000
4Pharmaceutical PreparationsIBA
07/2015 - 09/2000
4Complementary DNA (cDNA)IBA
06/2003 - 12/2000
4AntigensIBA
05/2001 - 06/2000
3Matrix Metalloproteinases (MMPs)IBA
08/2012 - 08/2000
3Biological ProductsIBA
08/2012 - 12/2000
3Immunoglobulin G (IgG)IBA
11/2005 - 08/2000
3Interleukin-6 (Interleukin 6)IBA
01/2003 - 01/2000
3Pancreatic Elastase (Elastase)IBA
11/2001 - 09/2000
3Antineoplastic Agents (Antineoplastics)IBA
11/2001 - 05/2000
3beta CateninIBA
11/2001 - 07/2000
3Keratins (Keratin)IBA
09/2001 - 06/2000
3Glycogen Phosphorylase (Phosphorylase, Glycogen)IBA
07/2001 - 01/2000
3Indicators and Reagents (Reagents)IBA
05/2001 - 01/2001
3Carcinoembryonic AntigenIBA
02/2001 - 05/2000
3Protease Inhibitors (Protease Inhibitor)IBA
01/2001 - 12/2000
3Chemotactic FactorsIBA
12/2000 - 01/2000
3Dopamine (Intropin)FDA LinkGeneric
07/2000 - 01/2000
2Insulin (Novolin)FDA Link
06/2016 - 03/2001
2rebamipideIBA
07/2009 - 01/2003
2Anti-Bacterial Agents (Antibiotics)IBA
05/2007 - 01/2001
2Capsules (Microcapsules)IBA
03/2007 - 10/2001
2lipoprotein-associated coagulation inhibitor (TFPI)IBA
02/2007 - 11/2001
2Interleukin-8 (Interleukin 8)IBA
03/2005 - 03/2001
2Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)IBA
01/2005 - 05/2000
2Butyric Acid (Butanoic Acid)IBA
01/2003 - 11/2001
2Tissue Plasminogen Activator (Alteplase)FDA Link
09/2002 - 11/2001
2CitrullineIBA
12/2001 - 01/2001
2Fibrinogen (Factor I)FDA Link
11/2001 - 10/2000
2TCF Transcription FactorsIBA
11/2001 - 07/2000
2Granulocyte Colony-Stimulating Factor (G-CSF)IBA
11/2001 - 04/2000
2AnthracyclinesIBA
11/2001 - 11/2001
2Factor VII (Proconvertin)IBA
11/2001 - 10/2000
2Thromboplastin (Tissue Factor)IBA
11/2001 - 10/2000
2Hemoglobins (Hemoglobin)IBA
11/2001 - 11/2001
2Cyclophosphamide (Cytoxan)FDA LinkGeneric
11/2001 - 04/2000
2Tumor Biomarkers (Tumor Markers)IBA
11/2001 - 09/2001
2amrubicinIBA
11/2001 - 11/2001
2Therapeutic UsesIBA
09/2001 - 03/2000
2Genetic Markers (Genetic Marker)IBA
09/2001 - 02/2001
2Biomarkers (Surrogate Marker)IBA
07/2001 - 01/2000
2Proliferating Cell Nuclear Antigen (PCNA)IBA
06/2001 - 01/2001

Therapy/Procedure

17Therapeutics
06/2013 - 01/2000
4Drug Therapy (Chemotherapy)
01/2021 - 11/2000
4Gastrectomy
01/2003 - 01/2001
4Lymph Node Excision (Lymph Node Dissection)
01/2003 - 01/2001
3Radiotherapy
10/2015 - 03/2001
3Laparotomy
10/2001 - 11/2000
2Ligation
03/2010 - 01/2001
2Combination Drug Therapy (Combination Chemotherapy)
11/2001 - 02/2001
2Thoracotomy
10/2001 - 03/2000
2Radiofrequency Ablation
10/2001 - 05/2001
2Liver Transplantation
09/2001 - 06/2000